**Core Concept**
Methylxanthines, a class of compounds that includes caffeine, theophylline, and theobromine, exert their effects through the inhibition of phosphodiesterase (PDE) enzymes. This action leads to an increase in intracellular concentrations of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), resulting in various physiological effects.

**Why the Correct Answer is Right**
Methylxanthines inhibit PDE enzymes, specifically PDE3 and PDE4, which are responsible for the breakdown of cAMP and cGMP. By inhibiting these enzymes, methylxanthines prevent the degradation of cAMP and cGMP, leading to an accumulation of these second messengers. This increase in cAMP and cGMP activates protein kinase A (PKA) and protein kinase G (PKG), respectively, resulting in the activation of various downstream pathways that mediate the physiological effects of methylxanthines.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not directly related to the cellular/molecular mechanism of action of methylxanthines.

**Option B:** While methylxanthines may have a stimulatory effect on the nervous system, this is not the primary mechanism of action at the cellular/molecular level.

**Option C:** This option is not a known action of methylxanthines at the cellular/molecular level.

**Clinical Pearl / High-Yield Fact**
Methylxanthines are often used as bronchodilators in the treatment of asthma and chronic obstructive pulmonary disease (COPD), as they relax smooth muscle in the airways and increase cAMP levels, leading to bronchodilation.

**Correct Answer:** C. Inhibition of phosphodiesterase enzymes.